A Study on the Correlation Between Tear Iron Levels and the Severity of Dry Eye Disease.
1 other identifier
observational
52
1 country
1
Brief Summary
This study aims to see if the amount of iron in tears is linked to how severe dry eye disease is. We hope this can lead to a new way to help diagnose and understand dry eye. This is an observational study. We will compare tear samples from people with dry eye to samples from people with healthy eyes. We will measure the iron content in the tears and see if it correlates with standard dry eye test results and symptom scores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2026
CompletedFirst Posted
Study publicly available on registry
January 23, 2026
CompletedStudy Start
First participant enrolled
February 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2029
February 10, 2026
January 1, 2026
3.2 years
January 5, 2026
February 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation between tear fluid iron concentration and dry eye symptom severity
The strength of association between the concentration of iron (in μg/mL) in tear fluid collected via Schirmer strips and the total score on the Ocular Surface Disease Index (OSDI) questionnaire.
baseline
Secondary Outcomes (3)
Correlation between tear fluid iron concentration and tear film stability
baseline
Correlation between tear fluid iron concentration and tear secretion volume
baseline
Correlation between tear fluid iron concentration and corneal epithelial damage
baseline
Study Arms (2)
CON
DED
Interventions
This is an observational study; no therapeutic intervention is administered. All participants undergo a single, standardized study visit that includes: Tear Fluid Collection: Tear samples are collected using sterile Schirmer test strips (without anesthesia) placed in the lower conjunctival sac for 5 minutes. Comprehensive Ocular Surface Evaluation: Symptom Assessment: Completion of the Ocular Surface Disease Index (OSDI) questionnaire. Clinical Tests: Measurement of fluorescein tear film breakup time (FBUT), corneal fluorescein staining (CFS) scoring, and Schirmer I test. The collected tear samples are subsequently analyzed for iron concentration. All procedures are diagnostic and evaluative in nature.
Eligibility Criteria
Based on your study protocol, here is the description for the "Study Population Description" field: This single-center, cross-sectional study will recruit participants from the patient population and staff/community at the Ophthalmology Department of Shanghai Changzheng Hospital. The Dry Eye Disease (DED) group will consist of consecutive patients presenting to the clinic who are diagnosed with DED according to the 2024 Chinese Expert Consensus criteria. The healthy control group will be recruited through hospital staff volunteers and community advertisements. All participants will be enrolled during the specified study period from the single site.
You may qualify if:
- Aged between 18 and 70 years, inclusive.
- Willing and able to provide written informed consent.
You may not qualify if:
- History or clinical suspicion of significant systemic conditions: hematologic diseases, severe systemic infections, malignancies (treated or untreated), or chronic hepatic/renal insufficiency.
- Use of artificial tears or any topical eye drops within 2 hours prior to examination.
- Active ocular allergy, infection, or severe blepharitis within the past 1 month.
- Systemic or topical use of antibiotics, corticosteroids, NSAIDs, or immunosuppressants within the past 1 month.
- History of contact lens wear within the past 1 month.
- History of blood transfusion, ocular surgery, or significant ocular trauma within the past 6 months.
- Women who are pregnant, breastfeeding, or postmenopausal women undergoing hormone replacement therapy.
- Known hypersensitivity to fluorescein sodium.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Changzheng Hospital
Shanghai, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Ophthalmology
Study Record Dates
First Submitted
January 5, 2026
First Posted
January 23, 2026
Study Start
February 6, 2026
Primary Completion (Estimated)
May 1, 2029
Study Completion (Estimated)
May 1, 2029
Last Updated
February 10, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share